<DOC>
	<DOCNO>NCT00629889</DOCNO>
	<brief_summary>RATIONALE : Levetiracetam pregabalin drug treat seizure . It yet know drug effective treating seizure cause primary brain tumor . PURPOSE : This randomized phase II trial study side effect well levetiracetam pregabalin work treat seizure patient undergo chemotherapy and/or radiation therapy primary brain tumor .</brief_summary>
	<brief_title>Levetiracetam Pregabalin Treating Seizures Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : - To determine safety efficacy antiepileptic drug monotherapy comprise levetiracetam pregabalin treat seizure patient undergo chemotherapy and/or radiotherapy primary brain tumor . OUTLINE : This multicenter study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive levetiracetam . - Arm II : Patients receive pregabalin . Patients follow 2 week , 2 month , 6 month , 1 year .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis primary brain tumor WHO grade IIIV disease Undergoing chemotherapy and/or radiotherapy No brain tumor without potential need chemotherapy ( e.g. , meningioma without anaplastic feature ) Has least one seizure provoke brain tumor , justify introduction antiepileptic drug ( AED ) treatment No status epilepticus PATIENT CHARACTERISTICS : Modified Rankin score &lt; 4 study enrollment Life expectancy â‰¥ 4 week Not pregnant Negative pregnancy test Fertile patient must use effective contraception No know intolerance study drug No preexist psychosis and/or current suicidality PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent IV AEDs benzodiazepines Other concurrent AEDs , except phenobarbital , allow provide discontinue within 2 week study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>seizure</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult diffuse astrocytoma</keyword>
	<keyword>adult pineal gland astrocytoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult supratentorial primitive neuroectodermal tumor ( PNET )</keyword>
	<keyword>adult ependymoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult anaplastic meningioma</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult papillary meningioma</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>adult grade II meningioma</keyword>
</DOC>